Listed

Prokidney Corp.

PROKNasdaqCIK 1850270HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$150.0k, Q2 FY2026
Operating income−$48.4m, Q2 FY2026
Net income−$28.4m, Q2 FY2026
Prokidney Corp., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$76.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2025, three months to 2025-03-31$230.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.2Revenue, Q2 FY2025, three months to 2025-06-30$221.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure0.2Revenue, Q3 FY2025, three months to 2025-09-30$217.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure0.2Revenue, Q4 FY2025, three months to 2025-12-31$225.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2026, three months to 2026-03-31$226.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.2Revenue, Q2 FY2026, three months to 2026-06-30$150.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Research and development$m32.2Research and development, Q3 FY2023, three months to 2023-09-30$32.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure22.5Research and development, Q4 FY2023, three months to 2023-12-31$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure27.2Research and development, Q1 FY2024, three months to 2024-03-31$27.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure29.4Research and development, Q2 FY2024, three months to 2024-06-30$29.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure31.3Research and development, Q3 FY2024, three months to 2024-09-30$31.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure39.8Research and development, Q4 FY2024, three months to 2024-12-31$39.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure27.3Research and development, Q1 FY2025, three months to 2025-03-31$27.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure25.9Research and development, Q2 FY2025, three months to 2025-06-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure26.8Research and development, Q3 FY2025, three months to 2025-09-30$26.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure34.2Research and development, Q4 FY2025, three months to 2025-12-31$34.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure33.8Research and development, Q1 FY2026, three months to 2026-03-31$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure36.1Research and development, Q2 FY2026, three months to 2026-06-30$36.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Operating income$m(46.6)Operating income, Q3 FY2023, three months to 2023-09-30−$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure(24.2)Operating income, Q4 FY2023, three months to 2023-12-31−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(40.1)Operating income, Q1 FY2024, three months to 2024-03-31−$40.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure(43.1)Operating income, Q2 FY2024, three months to 2024-06-30−$43.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure(49.0)Operating income, Q3 FY2024, three months to 2024-09-30−$49.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(51.6)Operating income, Q4 FY2024, three months to 2024-12-31−$51.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(41.4)Operating income, Q1 FY2025, three months to 2025-03-31−$41.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(39.7)Operating income, Q2 FY2025, three months to 2025-06-30−$39.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(38.5)Operating income, Q3 FY2025, three months to 2025-09-30−$38.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(45.4)Operating income, Q4 FY2025, three months to 2025-12-31−$45.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(44.9)Operating income, Q1 FY2026, three months to 2026-03-31−$44.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(48.4)Operating income, Q2 FY2026, three months to 2026-06-30−$48.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$15.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Income tax$m0.9Income tax, Q3 FY2023, three months to 2023-09-30$913.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure2.8Income tax, Q4 FY2023, three months to 2023-12-31$2.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$98.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure(0.1)Income tax, Q2 FY2024, three months to 2024-06-30−$56.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure(2.3)Income tax, Q3 FY2024, three months to 2024-09-30−$2.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure1.7Income tax, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2025, three months to 2025-03-31$591.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.8Income tax, Q2 FY2025, three months to 2025-06-30$848.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure0.6Income tax, Q3 FY2025, three months to 2025-09-30$560.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(1.6)Income tax, Q4 FY2025, three months to 2025-12-31−$1.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Net income$m(11.0)Net income, Q3 FY2023, three months to 2023-09-30−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure(5.7)Net income, Q4 FY2023, three months to 2023-12-31−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2024, three months to 2024-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure(12.5)Net income, Q2 FY2024, three months to 2024-06-30−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure(17.9)Net income, Q3 FY2024, three months to 2024-09-30−$17.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(21.3)Net income, Q4 FY2024, three months to 2024-12-31−$21.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(16.7)Net income, Q1 FY2025, three months to 2025-03-31−$16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(16.6)Net income, Q2 FY2025, three months to 2025-06-30−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(16.5)Net income, Q3 FY2025, three months to 2025-09-30−$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(19.2)Net income, Q4 FY2025, three months to 2025-12-31−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(20.0)Net income, Q1 FY2026, three months to 2026-03-31−$20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(28.4)Net income, Q2 FY2026, three months to 2026-06-30−$28.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Cash and equivalents$74.9m, Q2 FY2026
Shareholders' equity−$883.5m, Q2 FY2026
Prokidney Corp., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m191Cash and equivalents, Q3 FY2023, at 2023-09-30$191.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0000950170-23-063688.Report this figure60.6Cash and equivalents, FY2023, at 2023-12-31$60.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0000950170-25-040483.Report this figure84.4Cash and equivalents, Q1 FY2024, at 2024-03-31$84.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0000950170-24-057785.Report this figure215Cash and equivalents, Q2 FY2024, at 2024-06-30$214.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0000950170-24-094732.Report this figure108Cash and equivalents, Q3 FY2024, at 2024-09-30$108.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure99.1Cash and equivalents, FY2024, at 2024-12-31$99.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure97.8Cash and equivalents, Q1 FY2025, at 2025-03-31$97.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure84.9Cash and equivalents, Q2 FY2025, at 2025-06-30$84.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure95.3Cash and equivalents, Q3 FY2025, at 2025-09-30$95.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure109Cash and equivalents, FY2025, at 2025-12-31$108.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure102Cash and equivalents, Q1 FY2026, at 2026-03-31$101.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure74.9Cash and equivalents, Q2 FY2026, at 2026-06-30$74.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Current assets$m406Current assets, Q3 FY2023, at 2023-09-30$406.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063688.Report this figure374Current assets, FY2023, at 2023-12-31$374.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040483.Report this figure340Current assets, Q1 FY2024, at 2024-03-31$340.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057785.Report this figure450Current assets, Q2 FY2024, at 2024-06-30$450.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094732.Report this figure430Current assets, Q3 FY2024, at 2024-09-30$430.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure396Current assets, FY2024, at 2024-12-31$395.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure360Current assets, Q1 FY2025, at 2025-03-31$359.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure324Current assets, Q2 FY2025, at 2025-06-30$324.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure300Current assets, Q3 FY2025, at 2025-09-30$300.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure281Current assets, FY2025, at 2025-12-31$280.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure235Current assets, Q1 FY2026, at 2026-03-31$234.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure190Current assets, Q2 FY2026, at 2026-06-30$189.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Total assets$m452Total assets, Q3 FY2023, at 2023-09-30$451.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063688.Report this figure421Total assets, FY2023, at 2023-12-31$420.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0000950170-25-040483.Report this figure388Total assets, Q1 FY2024, at 2024-03-31$387.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0000950170-24-057785.Report this figure499Total assets, Q2 FY2024, at 2024-06-30$499.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0000950170-24-094732.Report this figure475Total assets, Q3 FY2024, at 2024-09-30$474.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure441Total assets, FY2024, at 2024-12-31$441.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure406Total assets, Q1 FY2025, at 2025-03-31$406.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure372Total assets, Q2 FY2025, at 2025-06-30$372.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure352Total assets, Q3 FY2025, at 2025-09-30$351.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure336Total assets, FY2025, at 2025-12-31$335.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure293Total assets, Q1 FY2026, at 2026-03-31$292.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure249Total assets, Q2 FY2026, at 2026-06-30$249.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Current liabilities$m21.0Current liabilities, Q3 FY2023, at 2023-09-30$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063688.Report this figure25.0Current liabilities, FY2023, at 2023-12-31$25.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0000950170-25-040483.Report this figure19.3Current liabilities, Q1 FY2024, at 2024-03-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057785.Report this figure20.6Current liabilities, Q2 FY2024, at 2024-06-30$20.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094732.Report this figure25.2Current liabilities, Q3 FY2024, at 2024-09-30$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure36.2Current liabilities, FY2024, at 2024-12-31$36.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure32.8Current liabilities, Q1 FY2025, at 2025-03-31$32.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure28.3Current liabilities, Q2 FY2025, at 2025-06-30$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure29.1Current liabilities, Q3 FY2025, at 2025-09-30$29.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure30.7Current liabilities, FY2025, at 2025-12-31$30.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure25.9Current liabilities, Q1 FY2026, at 2026-03-31$25.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure22.7Current liabilities, Q2 FY2026, at 2026-06-30$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Total liabilities$m23.6Total liabilities, Q3 FY2023, at 2023-09-30$23.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0000950170-23-063688.Report this figure29.2Total liabilities, FY2023, at 2023-12-31$29.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0000950170-25-040483.Report this figure24.7Total liabilities, Q1 FY2024, at 2024-03-31$24.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0000950170-24-057785.Report this figure26.8Total liabilities, Q2 FY2024, at 2024-06-30$26.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0000950170-24-094732.Report this figure31.3Total liabilities, Q3 FY2024, at 2024-09-30$31.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure39.4Total liabilities, FY2024, at 2024-12-31$39.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure36.1Total liabilities, Q1 FY2025, at 2025-03-31$36.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure32.7Total liabilities, Q2 FY2025, at 2025-06-30$32.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure33.3Total liabilities, Q3 FY2025, at 2025-09-30$33.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure34.8Total liabilities, FY2025, at 2025-12-31$34.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure29.7Total liabilities, Q1 FY2026, at 2026-03-31$29.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure26.2Total liabilities, Q2 FY2026, at 2026-06-30$26.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure
Shareholders' equity$m(1,093)Shareholders' equity, Q3 FY2023, at 2023-09-30−$1.09bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125312.Report this figure(1,103)Shareholders' equity, FY2023, at 2023-12-31−$1.10bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-18, accession 0001193125-26-113881.Report this figure(1,096)Shareholders' equity, Q1 FY2024, at 2024-03-31−$1.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0000950170-25-107352.Report this figure(972)Shareholders' equity, Q2 FY2024, at 2024-06-30−$972.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(980)Shareholders' equity, Q3 FY2024, at 2024-09-30−$979.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(995)Shareholders' equity, FY2024, at 2024-12-31−$995.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(999)Shareholders' equity, Q1 FY2025, at 2025-03-31−$998.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(1,003)Shareholders' equity, Q2 FY2025, at 2025-06-30−$1.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(1,008)Shareholders' equity, Q3 FY2025, at 2025-09-30−$1.01bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274303.Report this figure(1,011)Shareholders' equity, FY2025, at 2025-12-31−$1.01bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(1,024)Shareholders' equity, Q1 FY2026, at 2026-03-31−$1.02bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure(884)Shareholders' equity, Q2 FY2026, at 2026-06-30−$883.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-342373.Report this figure

Cash flow

Operating cash flow−$40.4m, Q2 FY2026
Capital expenditure$3.8m, Q2 FY2026
Prokidney Corp., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(23.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125312. Derived: 9-month figure less the 6-month figure.Report this figure(25.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(34.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$34.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure(38.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$38.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107352. Derived: 6-month figure less the 3-month figure.Report this figure(29.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$29.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274303. Derived: 9-month figure less the 6-month figure.Report this figure(24.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$24.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(29.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$29.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(31.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$31.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342373. Derived: 6-month figure less the 3-month figure.Report this figure(26.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$26.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274303. Derived: 9-month figure less the 6-month figure.Report this figure(32.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$32.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure(41.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$41.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure(40.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342373. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m27.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$27.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125312. Derived: 9-month figure less the 6-month figure.Report this figure1.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$960.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-069251.Report this figure0.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$636.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107352. Derived: 6-month figure less the 3-month figure.Report this figure2.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274303. Derived: 9-month figure less the 6-month figure.Report this figure25.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$25.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure3.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342373. Derived: 6-month figure less the 3-month figure.Report this figure5.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274303. Derived: 9-month figure less the 6-month figure.Report this figure5.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001193125-26-113881. Derived: 12-month figure less the 9-month figure.Report this figure3.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-225841.Report this figure3.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342373. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.